Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia
Top Cited Papers
- 1 November 2004
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 117 (10), 755-761
- https://doi.org/10.1016/j.amjmed.2004.06.032
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Efficacy and Safety of Low-Dose Aspirin in Polycythemia VeraNew England Journal of Medicine, 2004
- Polycythemia vera: myths, mechanisms, and managementBlood, 2002
- The World Health Organization (WHO) classification of the myeloid neoplasmsBlood, 2002
- Follow‐up examinations including sequential bone marrow biopsies in essential thrombocythemia (ET): A retrospective clinicopathological study of 120 patientsAmerican Journal of Hematology, 2002
- Polycythemia Vera: The Natural History of 1213 Patients Followed for 20 YearsAnnals of Internal Medicine, 1995
- Trends in the incidence of polycythemia vera among olmsted county, Minnesota residents, 1935–1989American Journal of Hematology, 1994
- Essential thrombocythemias. Clinical evolutionary and biological dataCancer, 1986
- Criteria for the Diagnosis of Acute Leukemia of Megakaryocyte Lineage (M7)Annals of Internal Medicine, 1985
- Epidemiology of coronary heart disease: The Framingham studyAmerican Journal Of Medicine, 1984
- Primary or Hemorrhagic ThrombocythemiaArchives of Internal Medicine, 1968